81 related articles for article (PubMed ID: 28109028)
41. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Delta fusion protein vaccine in an animal model.
Qian X; Lu Y; Liu Q; Chen K; Zhao Q; Song J
Immunol Lett; 2006 Feb; 102(2):191-201. PubMed ID: 16242781
[TBL] [Abstract][Full Text] [Related]
42. Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles.
Dupuy C; Buzoni-Gatel D; Touze A; Le Cann P; Bout D; Coursaget P
Microb Pathog; 1997 Apr; 22(4):219-25. PubMed ID: 9140917
[TBL] [Abstract][Full Text] [Related]
43. Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor.
Jin HS; Park EK; Lee JM; NamKoong SE; Kim DG; Lee YJ; Jun HJ; Han BD; Bae SM; Ahn WS
Gynecol Oncol; 2005 May; 97(2):559-67. PubMed ID: 15863160
[TBL] [Abstract][Full Text] [Related]
44. MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study.
Albarran Y Carvajal A; de la Garza A; Cruz Quiroz BJ; Vazquez Zea E; Díaz Estrada I; Mendez Fuentez E; López Contreras M; Andrade-Manzano A; Padilla S; Varela AR; Rosales R
BioDrugs; 2007; 21(1):47-59. PubMed ID: 17263589
[TBL] [Abstract][Full Text] [Related]
45. An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells.
Zhang L; Tang Y; Akbulut H; Zelterman D; Linton PJ; Deisseroth AB
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15101-6. PubMed ID: 14645711
[TBL] [Abstract][Full Text] [Related]
46. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
[TBL] [Abstract][Full Text] [Related]
47. Definition of an HPV18/45 cross-reactive human T-cell epitope after DNA immunisation of HLA-A2/KB transgenic mice.
McCarthy C; Youde SJ; Man S
Int J Cancer; 2006 May; 118(10):2514-21. PubMed ID: 16353149
[TBL] [Abstract][Full Text] [Related]
48. Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens.
Wu L; Kong WP; Nabel GJ
J Virol; 2005 Jul; 79(13):8024-31. PubMed ID: 15956548
[TBL] [Abstract][Full Text] [Related]
49. Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector.
Gao L; Chain B; Sinclair C; Crawford L; Zhou J; Morris J; Zhu X; Stauss H
J Gen Virol; 1994 Jan; 75 ( Pt 1)():157-64. PubMed ID: 7509369
[TBL] [Abstract][Full Text] [Related]
50. Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts.
Peters C; Paterson Y
Vaccine; 2003 Mar; 21(11-12):1187-94. PubMed ID: 12559797
[TBL] [Abstract][Full Text] [Related]
51. The Induction of the Synthesis of Interferon, CD4 and CD8 T Lymphocytes in Blood and Spleen of Mice after Oral Vaccination with the "Early" Protein HPV16 E2.
Salyaev RK; Rekoslavskaya NI; Stolbikov AS
Dokl Biochem Biophys; 2019 Sep; 488(1):316-319. PubMed ID: 31768850
[TBL] [Abstract][Full Text] [Related]
52. HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology.
Zhang GL; Riemer AB; Keskin DB; Chitkushev L; Reinherz EL; Brusic V
Database (Oxford); 2014; 2014():bau031. PubMed ID: 24705205
[TBL] [Abstract][Full Text] [Related]
53. Identification of T-cell epitopes using ELISpot and peptide pool arrays.
Tobery TW; Caulfield MJ
Methods Mol Med; 2004; 94():121-32. PubMed ID: 14959826
[TBL] [Abstract][Full Text] [Related]
54. Origin and evolution of papillomavirus (onco)genes and genomes.
Willemsen A; Bravo IG
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180303. PubMed ID: 30955499
[TBL] [Abstract][Full Text] [Related]
55. Vaccines based on whole recombinant Saccharomyces cerevisiae cells.
Ardiani A; Higgins JP; Hodge JW
FEMS Yeast Res; 2010 Dec; 10(8):1060-9. PubMed ID: 20707820
[TBL] [Abstract][Full Text] [Related]
56. Papillomaviruses: Viral evolution, cancer and evolutionary medicine.
Bravo IG; Félez-Sánchez M
Evol Med Public Health; 2015 Jan; 2015(1):32-51. PubMed ID: 25634317
[TBL] [Abstract][Full Text] [Related]
57. Novel Antigenic Targets of HPV Therapeutic Vaccines.
Boilesen DR; Nielsen KN; Holst PJ
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835193
[TBL] [Abstract][Full Text] [Related]
58. Design and Immunological Validation of
Neckermann P; Boilesen DR; Willert T; Pertl C; Schrödel S; Thirion C; Asbach B; Holst PJ; Wagner R
Front Immunol; 2021; 12():761214. PubMed ID: 34777375
[TBL] [Abstract][Full Text] [Related]
59. A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins.
Hancock G; Blight J; Lopez-Camacho C; Kopycinski J; Pocock M; Byrne W; Price MJ; Kemlo P; Evans RI; Bloss A; Saunders K; Kirton R; Andersson M; Hellner K; Reyes-Sandoval A; Dorrell L
Sci Rep; 2019 Dec; 9(1):18713. PubMed ID: 31822717
[TBL] [Abstract][Full Text] [Related]
60. Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma.
Ma M; Feng Y; Fan P; Yao X; Peng Y; Dong T; Wang R
Infect Agent Cancer; 2018; 13():35. PubMed ID: 30479656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
